The Medulloblastoma Initiative (MBI) was featured on the CNN Brasil website, in a report that highlights the impact of our innovative model for accelerating science.
In just 30 months, we have raised more than $11 million, established partnerships with 16 leading institutions in the United States, Canada, and Germany, and accelerated discoveries that previously took more than a decade to reach patients. The model, recognized by MIT, is now seen as a global reference in collaborative funding for rare diseases.
Among the advances underway are the first clinical trial with FDA-approved immunotherapy, which stimulates the body’s own immune response against tumor cells, and the development of an mRNA-based vaccine, with global distribution potential.
About CNN and CNN Brasil
Being featured on CNN, one of the most influential news networks in the world, and on CNN Brasil, a national reference in multiplatform journalism, reinforces the relevance and credibility of MBI’s work.
Launched in 2019, CNN Brasil combines editorial independence with the strength of a globally recognized brand, as part of the WarnerMedia conglomerate. In Brazil, it brings visibility to stories that matter, connecting millions of people every day through TV, its website, social media, and podcasts.
Being featured on CNN’s website reinforces the relevance and urgency of our work.
Read the full article on CNN
